AACR Annual Meeting 2026

April 17–22, 2026 · San Diego · 2418 items

Over 22,000 attendees and more than 7,400 abstracts, including a record 265 clinical trial abstracts. This section collects on-site analysis across fifteen signal directions, plus late-breaking, clinical-trial and new-drug abstracts.

Apr 22Wed

Wednesday · 30 items

20:26
x.com@Score6060
What a pleasure to talk with Ziren Kong and Jiangang Zhang about their exciting work! #AACR26 @CCR_AACR https://t.co/rfpJlOgqrR
Heat 53 likes0 replies2 reposts
20:25
x.com@Score6060
#AACR26 A very thoughtful discussion on perioperative immunotherapy and adenosine in particular, noting the need to design robust sample ...
Heat 86 likes0 replies2 reposts
20:25
x.com@Score6060
#AACR26 How does it fare vs other adenosine studies? Oleclumab (anti-CD73) was studied in NeoCOAST-2 and showed pCR 20.3% (16% in PDL1 ne...
oleclumabHeat 54 likes1 reply0 reposts
20:25
x.com@Score6060
#AACR26 The adenosine pathway is an appealing target given its immunosuppressive role. IPH5201 targets CD39 and has in vitro synergy with...
Same topic durvalumab · 8 peopleHeat 1110 likes1 reply0 reposts
20:25
x.com@Score6060
#AACR26 In MATISSE, need to acknowledge the heterogeneity and going forward, should we distinguish N2 vs non-N2? pCR rates of IPH5201 + d...
Heat 32 likes1 reply0 reposts
20:25
x.com@Score6060
Dr. Tina Cascone with an insightful discussion on the MATISSE trial at #AACR26 plenary session. Outlines the current state of neoadjuvant...
Heat 10876 likes4 replies28 reposts
20:20
x.com@Score6060
Congratulations to Ziren Kong on his simultaneous publication in @CCR_AACR at #AACR26! Editor-in-Chief Timothy Yap stopping by the poster...
Heat 11 like0 replies0 reposts
20:16
x.com@Score6060
We shared preclinical data on our CCNE1-directed MGD at #AACR26, highlighting a potential first-in-class approach to a frequently amplifi...
Same topic MRT-55811 · 2 peopleHeat 54 likes0 replies1 repost
20:12
x.com@Score6060
Data from the phase 2 MATISSE trial from @barlesi at #AACR26: perioperative IPH5201 (CD39 inhibitor) + durvalumab + neoadjuvant chemother...
Same topic durvalumab · 8 peopleHeat 5640 likes4 replies12 reposts
20:12
x.com@Score6060
#AACR26 Safety signals as expected: asthenia, arthralgias, hypothyroidism. Radiographic RR 62.5%. 87.5% of patients underwent resection (...
Heat 1812 likes0 replies6 reposts
19:56
x.com@Score6060
We’ve partnered with tertiary analysis platforms, Genomize, Geneyx, & Golden Helix to enhance our hereditary cancer panel. Combining ...
Heat 1110 likes0 replies1 repost
19:18
x.com@Score6060
Abstract CT011: Genomic HER2 amplification predicts for complete clinical response in a phase II study of induction tucatinib and trastuz...
CT011 tucatinib trastuzumab HER2Heat 2817 likes0 replies11 reposts
19:09
x.com@Score6060
Good morning San Diego!
Heat 2317 likes0 replies6 reposts
19:04
x.com@Score6060
.@AACR_CEO Margaret Foti shared the inaugural recipients of the Trailblazer Cancer Research Grants Program during the #AACR26 Opening Cer...
Heat 1611 likes0 replies5 reposts
18:57
x.com@Score6060
In this video presentation, the Avacta team discuss the AVA6103 (FAP-EXd) preclinical and clinical trial in progress highlights presented...
Same topic AVA6103 · 3 people #AVCTHeat 169148 likes0 replies21 reposts
18:57
x.com@Score6060
Replying to @theNCI #AACR26: “What cancer breakthroughs excite you?”
#ENDOMETRIAL #GYNCSMHeat 22 likes0 replies0 reposts
18:52
x.com@Score6060
#AACR26 As risk drives screening stratification in breast & colorectal cancers, could similar risk assessment tools be developed for ...
Same topic #GYNCSM · 3 peopleHeat 00 likes0 replies0 reposts
18:51
x.com@Score6060
Can’t attend #AACR26 this year? No worries, start exploring the latest advances in science and technology innovation today!
Heat 00 likes0 replies0 reposts
18:49
x.com@Score6060
Phase 1b/2 ZL-1310 (DLL3 ADC) in pretreated NECs presented by @rohit_thum at #AACR26 : ORR 38.2% (13/34), responses across multiple prima...
irinotecan ZL-1310 DLL3Heat 1710 likes3 replies4 reposts
18:36
x.com@Score6060
Mesmerizing insights from #AACR26! Exploring ULK1/2 inhibition's role in enhancing KRAS-targeted therapies could be a game-changer for ca...
Same topic MR-2088 · 2 people KRAS #MEDICINEHeat 00 likes0 replies0 reposts
18:35
x.com@Score6060
Mesmerizing insights from #AACR26! Exploring ULK1/2 inhibition's role in enhancing KRAS-targeted therapies could be a game-changer for ca...
Same topic MR-2088 · 2 people KRAS #MEDICINEHeat 00 likes0 replies0 reposts
18:20
x.com@Score6060
From $RVMD Revolution Medicines, more strong data on KRAS drug and a glimpse of a ‘novel class’ beyond it
Same topic RM-055 · 3 people KRASHeat 4941 likes1 reply7 reposts
18:16
x.com@Score6060
Track the Updates from Key Opinion Leaders regarding the most exciting data from #AACR26. https://t.co/4X5FZycguN
Heat 00 likes0 replies0 reposts
18:09
x.com@Score6060
Excited to see how these emerging insights at #AACR26 could translate into more effective, truly targeted options for patients in the nea...
#HEALTHCAREIT #EHEALTH #HEALTHCARE #DIGITALHEALTHHeat 42 likes0 replies2 reposts
17:01
x.com@Score6060
GI-102 (Subprotocol C) – daraxonrasib + GnP in 1L mPDAC shows early signal 👇
Same topic daraxonrasib · 64 people LB337 paclitaxel GI-102 KRAS #ONCOTWITTER #PANCREATICCANCERHeat 4025 likes1 reply14 reposts
16:50
x.com@Score6060
📅Wednesday 22 April at #AACR26
Heat 42 likes0 replies2 reposts
16:45
x.com@Score6060
Highlights from the penultimate day of #AACR26 yesterday, featuring plenary talks and presentations from teams PROSPECT, Mutographs, CAUS...
Heat 64 likes0 replies2 reposts
16:15
x.com@Score6060
Incredible buzz at #AACR26 around the daraxonrasib data in #mKRAS #PDAC exciting signals & real hope for patients. Huge congratulatio...
Same topic daraxonrasib · 64 people #MKRAS #PDACHeat 1812 likes0 replies6 reposts
15:49
x.com@Score6060
How do we make immunotherapy work better in HNSCC?
Same topic #HNSCC · 3 people #TUMORIMMUNOLOGY #EPIGENETICS #CHECKPOINTBLOCKADE #CANCERBIOLOGY #TRANSLATIONALRESEARCH #ORALCANCERHeat 32 likes0 replies1 repost
14:44
x.com@Score6060
No other technology uses FAP this way. Others may aim for a similar mechanism, but they lack this level of specificity.
Same topic #AVCT · 3 peopleHeat 4743 likes0 replies4 reposts